<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03776266</url>
  </required_header>
  <id_info>
    <org_study_id>SMC 2018-10-044</org_study_id>
    <nct_id>NCT03776266</nct_id>
  </id_info>
  <brief_title>The Long-term Clinical Outcomes and Patterns of Transfusion in PCI Patients: Retrospective Cohort Study</brief_title>
  <acronym>TFPCI</acronym>
  <official_title>The Five-year Pattern of Red Blood Cell Transfusion and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: A Korean Nationwide Longitudinal Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A nationwide retrospective cohort study. To investigate the long-term patterns of transfusion
      and clinical outcomes of patients undergoing PCI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A nationwide retrospective cohort study. Transfusion after PCI may increase a risk, but the
      long term effects after red blood cell transfusion is known. Longitudinal data is collected
      from administrative claims in the National Healthcare Insurance Service of Korea. All Korean
      patient date undergoing PCI inserting stent from January 1, 2011 to December 31, 2011 is
      extracted. Clinical outcomes until December 31, 2016 is investigated.

      Primary outcome is the incidence density of red blood cell transfusion. Secondary outcomes
      are the association of transfusion with major adverse clinical event (MACE) consisting
      all-cause death, revascularization, critically ill cardiovascular status, or stroke.

      Incidence density and time-dependent Cox proportional hazard regression is statistically
      analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 5, 2018</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence density of transfusion</measure>
    <time_frame>5 years</time_frame>
    <description>5-year incidence density of red blood cell transfusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence density of MACE</measure>
    <time_frame>5 years</time_frame>
    <description>5-year incidence densities of a major adverse clinical event (MACE) consisting of all-cause death, revascularization, critically ill cardiovascular status, and stroke</description>
  </secondary_outcome>
  <enrollment type="Actual">48786</enrollment>
  <condition>Erythrocyte Transfusion</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <condition>Revascularization</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No intervention is required due to retrospective observational study</intervention_name>
    <description>Red blood cell transfusion on or after percutaneous coronary intervention</description>
    <other_name>Observation on Red blood cell transfusion on or after percutaneous coronary intervention</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing PCI using stent in 2011 from all medical providers in Korea is
        selected using National Healthcare Insurance System
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All Korean patients undergoing PCI using stent from January 1, 2011 to December 31,
             2011

        Exclusion Criteria:

          -  Patients without any stent insertion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Ho Choi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Gang nam-Gu, Ilwon-Dong</state>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>December 13, 2018</study_first_submitted>
  <study_first_submitted_qc>December 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2018</study_first_posted>
  <last_update_submitted>March 26, 2019</last_update_submitted>
  <last_update_submitted_qc>March 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Jin-Ho Choi</investigator_full_name>
    <investigator_title>MD, PhD, Professor</investigator_title>
  </responsible_party>
  <keyword>Transfusion</keyword>
  <keyword>PCI</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

